<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Your Failed Blockbuster Drug Is My Nichebuster Therapy</title>
	<atom:link href="http://thedecisiontree.com/blog/2007/11/your-failed-blockbuster-drug-is-my-nichebuster-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>http://thedecisiontree.com/blog/2007/11/your-failed-blockbuster-drug-is-my-nichebuster-therapy/</link>
	<description>a blog about predictive medicine and the future of healthcare</description>
	<lastBuildDate>Wed, 05 Oct 2011 18:14:44 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Deepak Singh</title>
		<link>http://thedecisiontree.com/blog/2007/11/your-failed-blockbuster-drug-is-my-nichebuster-therapy/comment-page-1/#comment-633</link>
		<dc:creator>Deepak Singh</dc:creator>
		<pubDate>Tue, 13 Nov 2007 18:47:59 +0000</pubDate>
		<guid isPermaLink="false">http://epidemix.org/blog/?p=220#comment-633</guid>
		<description>It can actually be extended beyond pharmacogenomics as well.  Repurposing failed drugs is a viable business model for some companies.  Another alternative is to take drugs that failed trials due to solubility, etc issues and find new delivery vehicles for them that make them viable again.</description>
		<content:encoded><![CDATA[<p>It can actually be extended beyond pharmacogenomics as well.  Repurposing failed drugs is a viable business model for some companies.  Another alternative is to take drugs that failed trials due to solubility, etc issues and find new delivery vehicles for them that make them viable again.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

